G Bertoli
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Oncology 5
- Cancer-related Molecular Pathways 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Carlo Baroni (7 shared papers)Ν. Fabris (3 shared papers)Luciana Rigoli (1 shared paper)C Inferrera (1 shared paper)Rosario Alberto Caruso (1 shared paper)Rino Bellocco (1 shared paper)P Alquati (7 shared papers)Alessandra Bersiga (6 shared papers)
- Journals
- British Journal of Cancer (3 papers)Cellular and Molecular Life Sciences (2 papers)Acta Diabetologica (1 paper)Advances in experimental medicine and biology (1 paper)Diabetologia (1 paper)
- Partner nations
- ItalyUnited StatesEstonia
In The Last Decade
G Bertoli
24 papers receiving 747 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 180
- Oncology 224
- Immunology 177
- Endocrinology, Diabetes and Metabolism 96
- Behavioral Neuroscience 16
Countries citing papers authored by G Bertoli
This map shows the geographic impact of G Bertoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Bertoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Bertoli more than expected).
Fields of papers citing papers by G Bertoli
This network shows the impact of papers produced by G Bertoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Bertoli. The network helps show where G Bertoli may publish in the future.
Co-authors
The 25 scholars most cited alongside G Bertoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 158 | |
| 2 | p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. | 2000 | 105 |
| 3 | 1993 | 96 | |
| 4 | Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. | 1969 | 79 |
| 5 | 2001 | 69 | |
| 6 | Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours. | 1996 | 54 |
| 7 | Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. | 2002 | 42 |
| 8 | 1994 | 38 | |
| 9 | 2003 | 36 | |
| 10 | 1967 | 33 | |
| 11 | Effects of hormones on development and function of lymphoid tissues. II. Delayed development of immunological capacity in pituitary dwarf mice. | 1971 | 16 |
| 12 | 2003 | 13 | |
| 13 | 1970 | 12 | |
| 14 | 1968 | 8 | |
| 15 | Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma. | 1982 | 7 |
| 16 | 1999 | 6 | |
| 17 | 1966 | 5 | |
| 18 | 1998 | 4 | |
| 19 | 1969 | 3 | |
| 20 | Histochemistry of 3 beta-hydroxysteroid dehydrogenase in human testis in normal, dysgenetic and various pathological conditions. | 1969 | 3 |
About G Bertoli
G Bertoli is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 24 papers that have together received 796 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (3 papers), Cancer-related Molecular Pathways (2 papers), Breast Cancer Treatment Studies (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Sexual Differentiation and Disorders (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), HER2/EGFR in Cancer Research (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Cancer Research (180 citations), Oncology (224 citations), Immunology (177 citations), Endocrinology, Diabetes and Metabolism (96 citations) and Behavioral Neuroscience (16 citations). G Bertoli has collaborated with scholars based in Italy, United States and Estonia. Frequent co-authors include Carlo Baroni, Ν. Fabris, Luciana Rigoli, C Inferrera, Rosario Alberto Caruso, Rino Bellocco, P Alquati, Alessandra Bersiga, Alberto Bottini and Luigi Dogliotti. Their work appears in journals such as British Journal of Cancer, Cellular and Molecular Life Sciences, Acta Diabetologica, Advances in experimental medicine and biology and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.